Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production.

Shi Z, Yang WM, Chen LP, Yang DH, Zhou Q, Zhu J, Chen JJ, Huang RC, Chen ZS, Huang RP.

Breast Cancer Res Treat. 2012 Oct;135(3):737-47. doi: 10.1007/s10549-012-2196-0. Epub 2012 Aug 26.

PMID:
22923236
[PubMed - indexed for MEDLINE]
3.

Drug resistant breast cancer cells overexpress ETS1 gene.

Kars MD, Işeri OD, Gündüz U.

Biomed Pharmacother. 2010 Sep;64(7):458-62. doi: 10.1016/j.biopha.2010.01.008. Epub 2010 Feb 25.

PMID:
20392592
[PubMed - indexed for MEDLINE]
4.

[Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].

Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.

Zhonghua Fu Chan Ke Za Zhi. 2010 Sep;45(9):691-8. Chinese.

PMID:
21092551
[PubMed - indexed for MEDLINE]
5.

Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.

Ogretmen B, Safa AR.

Int J Cancer. 1996 Sep 4;67(5):608-14.

PMID:
8782646
[PubMed - indexed for MEDLINE]
6.

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP.

Mol Cancer Ther. 2008 Jul;7(7):2152-9. doi: 10.1158/1535-7163.MCT-08-0021.

PMID:
18645025
[PubMed - indexed for MEDLINE]
Free Article
7.

[Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].

Li CB, Zhang F, Shi YR, Wei XY, Yang Y, Niu RF.

Ai Zheng. 2004 Dec;23(12):1605-10. Chinese.

PMID:
15601546
[PubMed - indexed for MEDLINE]
8.

Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.

Ogretmen B, McCauley MD, Safa AR.

Biochemistry. 1998 Aug 18;37(33):11679-91.

PMID:
9709006
[PubMed - indexed for MEDLINE]
9.

Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.

Duan Z, Lamendola DE, Penson RT, Kronish KM, Seiden MV.

Cytokine. 2002 Mar 7;17(5):234-42.

PMID:
12027404
[PubMed - indexed for MEDLINE]
10.

Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.

Liu F, Fan D, Qi J, Zhu H, Zhou Y, Yang C, Zhu Z, Xiong D.

Life Sci. 2008 Sep 26;83(13-14):496-501. doi: 10.1016/j.lfs.2008.07.017. Epub 2008 Aug 3.

PMID:
18725232
[PubMed - indexed for MEDLINE]
11.

The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.

Kang Y, Park MA, Heo SW, Park SY, Kang KW, Park PH, Kim JA.

Biochim Biophys Acta. 2013 Mar;1830(3):2638-48.

PMID:
23246576
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.

Gouazé V, Liu YY, Prickett CS, Yu JY, Giuliano AE, Cabot MC.

Cancer Res. 2005 May 1;65(9):3861-7.

PMID:
15867385
[PubMed - indexed for MEDLINE]
Free Article
14.

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.

Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, Li LZ.

Cancer Lett. 2010 Sep 1;295(1):110-23. doi: 10.1016/j.canlet.2010.02.019. Epub 2010 Mar 16.

PMID:
20236757
[PubMed - indexed for MEDLINE]
15.

Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells.

Chadderton A, Villeneuve DJ, Gluck S, Kirwan-Rhude AF, Gannon BR, Blais DE, Parissenti AM.

Breast Cancer Res Treat. 2000 Feb;59(3):231-44.

PMID:
10832593
[PubMed - indexed for MEDLINE]
16.

Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).

Zhang X, Li J, Qiu Z, Gao P, Wu X, Zhou G.

Cancer Biol Ther. 2009 Jun;8(12):1117-21. Epub 2009 Jun 9.

PMID:
19502811
[PubMed - indexed for MEDLINE]
Free Article
17.

Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.

Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y.

Oncol Rep. 2010 May;23(5):1469-75.

PMID:
20372866
[PubMed - indexed for MEDLINE]
18.

pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines.

Martínez-Zaguilán R, Raghunand N, Lynch RM, Bellamy W, Martinez GM, Rojas B, Smith D, Dalton WS, Gillies RJ.

Biochem Pharmacol. 1999 May 1;57(9):1037-46.

PMID:
10796074
[PubMed - indexed for MEDLINE]
19.

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, Scala S, Shim H.

Biochem Pharmacol. 2010 Mar 15;79(6):817-24. doi: 10.1016/j.bcp.2009.10.017. Epub 2009 Oct 31.

PMID:
19883630
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].

Zhang YH, Li G, Yu J, Xu MS, Liu ZX.

Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):654-60. Chinese.

PMID:
22340044
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk